HELGI HELENE GISELA FRANZISKA JUNG COOK



DATOS GENERALES
Nombre completo   HELGI HELENE GISELA FRANZISKA JUNG COOK
Máximo nivel de estudios   DOCTORADO
Antigüedad académica en la UNAM   51 años
NOMBRAMIENTOS
Vigente   PROFESOR DE CARRERA TITULAR C TC Definitivo
Facultad de Química
Desde 01-02-2018
PROFESOR DE CARRERA TITULAR C TC Definitivo
Facultad de Química
Desde 01-01-2008 (fecha inicial de registros en el SIIA) hasta 31-01-2018
ESTIMULOS, PROGRAMAS, PREMIOS Y RECONOCIMIENTOS
* SNI III - VIGENTE
* PRIDE D - 2024

INFORMACIÓN DE PUBLICACIONES
Firmas  
Cook H.J. Cook, HJ Helene Jung-Cook, Helgi Helgi J.-C. Helgi, JC Jung C.H.
Jung Cook H. Jung Cook, Helgi Jung Cook, Helgi Helene Jung H. Jung, H Jung, Helgi
Jung-Cook H. Jung?Cook H. Jung-Cook H.H. JungCook, H Jung-Cook, H Jung-Cook, H.
Jung-Cook, Helgi Jung-Cook, Helgi Helene
ID's SCOPUS  
56000801200 56301455100 57211282787 7201617832
Áreas de conocimiento  
Agriculture, dairy and animal science Astronomy and astrophysics Biology Biotechnology and applied microbiology Clinical neurology
Crystallography Chemistry, analytical Chemistry, inorganic and nuclear Chemistry, medicinal Chemistry, multidisciplinary
Chemistry, organic Chemistry, physical Genetics and heredity Infectious diseases Instruments and instrumentation
Medicine, general and internal Medicine, research and experimental Neurosciences Parasitology Pharmacology & pharmacy
Pharmacology and pharmacy Physics, multidisciplinary Physics, nuclear Physics, particles & fields Physics, particles and fields
Psychiatry Public, environmental and occupational health Respiratory system Tropical medicine Veterinary sciences
Agricultural and Biological Sciences (miscellaneous) Animal Science and Zoology Biological psychiatry Biotechnology Clinical psychology
Chemical Engineering (miscellaneous) Chemistry (miscellaneous) Drug Discovery Engineering (miscellaneous) Health, toxicology and mutagenesis
Inorganic chemistry Instrumentation Materials Science (miscellaneous) Medicine (miscellaneous) Neurology
Neurology (clinical) Neuroscience (miscellaneous) Nuclear and high energy physics Parasitology Pharmaceutical science
Pharmacology Pharmacology (medical) Pharmacology, toxicology and pharmaceutics (miscellaneous) Physics and Astronomy (miscellaneous) Psychiatry and mental health
Veterinary (miscellaneous)
Coautorías con entidades de la UNAM  
  • Centro de Ciencias de la Atmósfera
  • Centro de Ciencias Genómicas
  • Centro de Nanociencias y Nanotecnología en la UNAM
  • Centro de Investigaciones en Geografía Ambiental en Morelia, Michoacán
  • Instituto de Biología
  • Instituto de Física
  • Instituto de Geofísica
  • Instituto de Geografía
  • Instituto de Investigaciones Biomédicas
  • Instituto de Química
  • Instituto de Investigaciones en Matemáticas Aplicadas y en Sistemas
  • Instituto de Ingeniería
  • Instituto de Investigaciones en Materiales
  • Instituto de Ciencias Nucleares
  • Instituto de Neurobiología en Querétaro, Querétaro
  • Instituto de Radioastronomía y Astrofísica
  • Facultad de Ciencias
  • Facultad de Ingeniería
  • Facultad de Medicina
  • Facultad de Química
  • Facultad de Medicina Veterinaria y Zootecnia
  • Facultad de Psicología
  • Escuela Nacional de Enfermería y Obstetricia
  • Escuela Nacional de Lenguas, Lingüística y Traducción
  • Facultad de Estudios Superiores "Cuautitlán"
  • Facultad de Estudios Superiores "Zaragoza"
  • Escuela Nacional de Estudios Superiores, Unidad Mérida, Yucatán
Revistas en las que ha publicado  (80):
  1. AAPS PHARMSCITECH, Estados Unidos America (2020, 2023)
  2. Abstracts Of Papers Of The American Chemical Society, Estados Unidos America (2015, 2017)
  3. ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, Dinamarca (2013)
  4. ACTA TROPICA, Países Bajos (2010, 2017, 2020)
  5. AIDS RESEARCH AND THERAPY, Reino Unido (2015)
  6. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Estados Unidos America (2014, 2025)
  7. Archives Of Medical Research, México (2024)
  8. Archivos de Neurociencias, México (2011)
  9. ARZNEIMITTEL-FORSCH, Alemania (2011)
  10. BIOLOGICAL PSYCHIATRY, Estados Unidos America (2018)
  11. BIOMEDICAL CHROMATOGRAPHY, Estados Unidos America (2012, 2016)
  12. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, Reino Unido (2014, 2017)
  13. Brain Sciences, Suiza (2023)
  14. BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, Brasil (2023)
  15. CRYSTAL GROWTH & DESIGN, Estados Unidos America (2016)
  16. Current Research in Pharmacology and Drug Discovery, Países Bajos (2025)
  17. CURRENT TOPICS IN MEDICINAL CHEMISTRY, (2008)
  18. CHEMICAL & PHARMACEUTICAL BULLETIN, Japón (2019)
  19. Chinese Journal of Psychiatry, China (2026)
  20. DISSOLUTION TECHNOLOGIES, Estados Unidos America (2023, 2025, 2026)
  21. Drug Metabolism and Drug Interactions, Alemania (2011, 2014)
  22. Drug Metabolism and Personalized Therapy, Alemania (2016)
  23. Electronic Journal Of Biotechnology, Chile (2016)
  24. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, Francia (2009)
  25. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, Países Bajos (2020)
  26. EUROPEAN PHYSICAL JOURNAL C, Estados Unidos America (2003, 2015, 2020)
  27. EXPERIMENTAL PARASITOLOGY, Estados Unidos America (2015, 2020)
  28. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, Reino Unido (2012, 2018)
  29. Farmacia, Rumania (2021)
  30. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, Alemania (2009)
  31. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, Suiza (2022)
  32. International Journal of Research in Pharmaceutical Sciences, India (2017)
  33. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, Francia (2010)
  34. Investigación médica internacional, (1999)
  35. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, Irán (2020)
  36. ITALIAN JOURNAL OF ANIMAL SCIENCE, Italia (2016)
  37. J CHROMATOGR B, (1993)
  38. JOURNAL OF CLINICAL PHARMACOLOGY, Estados Unidos America (2019, 2024)
  39. Journal Of Clinical Pharmacy And Therapeutics, Reino Unido (2013)
  40. JOURNAL OF HIGH ENERGY PHYSICS, Estados Unidos America (2015, 2020)
  41. JOURNAL OF INSTRUMENTATION, Reino Unido (2020)
  42. JOURNAL OF MOLECULAR STRUCTURE, Países Bajos (2023)
  43. JOURNAL OF PHARMACEUTICAL SCIENCES, Estados Unidos America (2020)
  44. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, Estados Unidos America (2021)
  45. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, Canada (2008)
  46. JOURNAL OF PHARMACY AND PHARMACOLOGY, Estados Unidos America (2010)
  47. Journal Of The Mexican Chemical Society, México (2018)
  48. JOURNAL OF THE NEUROLOGICAL SCIENCES, Países Bajos (2015)
  49. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, Estados Unidos America (2009)
  50. LATIN AMERICAN JOURNAL OF PHARMACY, Argentina (2017, 2018)
  51. Medicine, Estados Unidos America (2020)
  52. MULTIPLE SCLEROSIS JOURNAL, Reino Unido (2024)
  53. NATURE PHYSICS, Reino Unido (2015)
  54. Neurologia, España (2018)
  55. Neurology, Estados Unidos America (2019, 2020)
  56. OMICS, Estados Unidos America (2018)
  57. Pharmaceuticals, Suiza (2025)
  58. Pharmaceutics, Suiza (2023)
  59. Pharmacogenomics, Reino Unido (2014, 2016, 2020, 2021)
  60. PHARMACOGENOMICS JOURNAL, Reino Unido (2016, 2020)
  61. Pharmacology Communications, (1994)
  62. Pharmacopsychiatry, Alemania (2022)
  63. Pharmazie, Alemania (2009)
  64. PHYSICAL REVIEW C, Estados Unidos America (2015)
  65. PHYSICAL REVIEW D, Estados Unidos America (2015, 2017, 2018, 2020)
  66. PHYSICAL REVIEW LETTERS, Estados Unidos America (2018, 2020)
  67. PHYSICS LETTERS B, Países Bajos (2015, 2018, 2020)
  68. Phytochemistry, Reino Unido (1982)
  69. PLOS PATHOGENS, Estados Unidos America (2022)
  70. Psiquiatria Biologica, (2023)
  71. REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY, Brasil (2020)
  72. REVISTA DE BIOLOGIA TROPICAL, Costa Rica (2016)
  73. REVISTA DE PSIQUIATRIA Y SALUD MENTAL, España (2021)
  74. Revista Mexicana de Ciencias Farmaceuticas, México (2008, 2012, 2013)
  75. RSC ADVANCES, Reino Unido (2022)
  76. SAUDI PHARMACEUTICAL JOURNAL, Países Bajos (2017)
  77. TETRAHEDRON-ASYMMETRY, Reino Unido (2014)
  78. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, Estados Unidos America (2021)
  79. Trials, Reino Unido (2022)
  80. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, Nigeria (2018)


Descargar PDF

Documentos indexados (WoS y Scopus)

# Título del documento Autores Año Revista Fuente Citas WoS Citas Scopus
1An international adult guideline for making Clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and Clozapine levels?????CRP?????????????????????????????(??)Coautor: Jung-Cook H., de Leon J., Schoretsanitis G., Smith R.L., et al.2026Chinese Journal of PsychiatryScopus-id: 2-s2.0-105031498427
00
2Development of a Discriminative Dissolution Method for Mebendazole SuspensionsCoautor: Jung-Cook H., González-Hernández I., Mayet-Cruz L., Espinoza-Bañuelos D., et al.2026DISSOLUTION TECHNOLOGIESScopus-id: 2-s2.0-105033257264
00
3In Vitro Evaluation of Esters of Quinoxaline-1,4-di-N-oxide Derivatives as New Antitaeniasis Agents and Their Inhibitory Activity Against Triosephosphate IsomeraseCoautor: Jung-Cook H., Palomares-Alonso F., González-González A., Paz-González A.D., et al.2025PharmaceuticalsWoS-id: 001452750800001
Scopus-id: 2-s2.0-105001118606
01
4Development of a Discriminative Dissolution Method for Mebendazole SuspensionsCoautor: Jung-Cook H., González-Hernández I., Mayet-Cruz L., Espinoza-Bañuelos D., et al.2025DISSOLUTION TECHNOLOGIESWoS-id: 001503649500007
Scopus-id: 2-s2.0-105007000682
00
5Synergistic interaction between praziquantel and oxfendazole or fenbendazole in a murine cysticercosis modelCoautor: Helgi, JC, Francisca, PA, Angélica, GM, Rafael, RR, et al.2025ANTIMICROBIAL AGENTS AND CHEMOTHERAPYWoS-id: 001551333300001
Scopus-id: 2-s2.0-105017539430
00
6Melatonin combined with antineoplastic drugs or natural products for cancer treatment: An updateCoautor: Jung-Cook H., Trejo-Solís C., Rojas-Tomé I.S., Palomares-Alonso F.2025Current Research in Pharmacology and Drug DiscoveryScopus-id: 2-s2.0-105022198798
02
7Intranasal Versus Intravenous Dexamethasone to Treat Hospitalized COVID-19 Patients: A Randomized Multicenter Clinical TrialCoautor: Jung H., Cárdenas G., Chávez-Canales M., Espinosa A.M., et al.2024Archives Of Medical ResearchWoS-id: 001180032100001
Scopus-id: 2-s2.0-85183925251
35
8Population Pharmacokinetics of Sertraline in Psychiatric and Substance Use DisordersCoautor: Cook H.J., Castillo C.E.C., Garibay S.E.M., Segovia R.D.C.M., et al.2024JOURNAL OF CLINICAL PHARMACOLOGYWoS-id: 001215947400001
Scopus-id: 2-s2.0-85192568732
55
9Evaluation of the efficacy and safety of intranasal methylprednisolone for the treatment of relapses in patients with RRMSCoautor: Cook, HJ, Perez, KG, Bliskunova, T, Osorio, AAE, et al.2024MULTIPLE SCLEROSIS JOURNALWoS-id: 001324906903248
00
10Pharmacokinetic Study of Intranasal Dexamethasone and Methylprednisolone Compared with Intravenous Administration: Two Open-Label, Single-Dose, Two-Period, Two-Sequence, Cross-Over Study in Healthy VolunteersCoautor: Jung-Cook, Helgi, Cardenas, Graciela, Bobes, Raul J., Fragoso, Gladis, et al.2023PharmaceuticsWoS-id: 000927238400001
Scopus-id: 2-s2.0-85146768838
911
11Praziquanamine enantiomers: Crystal structure, Hirshfeld surface analysis, and quantum chemical studiesCoautor: Jung?Cook H., Cedillo?Cruz A., Villalobos?López D.C., Aguilar M.I., et al.2023JOURNAL OF MOLECULAR STRUCTUREWoS-id: 000951694200001
Scopus-id: 2-s2.0-85150025559
33
12Dissolution Specifications for Ibuprofen Soft Gelatin Capsules: A ProposalCoautor: Jung-Cook H., Mayet-Cruz L., Rodriguez J.M., Juárez-López E.2023DISSOLUTION TECHNOLOGIESWoS-id: 001010512900004
Scopus-id: 2-s2.0-85161401600
00
13Melatonin in Combination with Albendazole or Albendazole Sulfoxide Produces a Synergistic Cytotoxicity against Malignant Glioma Cells through Autophagy and ApoptosisCoautor: Jung-Cook, Helgi, Hernandez-Ceron, Miguel, Chavarria, Victor, Rios, Camilo, et al.2023Brain SciencesWoS-id: 001017059700001
Scopus-id: 2-s2.0-85164006683
24
14Development and Pharmacokinetic Evaluation of Two Parenteral Formulations of Albendazole Using Prodrug and Cosolvent ApproachesCoautor: Jung-Cook, Helgi, Becerril-Vega, Jose, Hernandez-Campos, Alicia, Gonzalez-Hernandez, Iliana, et al.2023AAPS PHARMSCITECHWoS-id: 001038668600003
Scopus-id: 2-s2.0-85165891667
12
15Analysis of the effect of in vitro dissolution on the pharmacokinetics of albendazoleCoautor: Jung-Cook, H, Castro, N, González-Hernández, I, Mayet-Cruz, L, et al.2023BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCESWoS-id: 001100943100001
Scopus-id: 2-s2.0-85176553916
11
16An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levelsCoautor: Jung-Cook H., de Leon J., Schoretsanitis G., Smith R.L., et al.2023Psiquiatria BiologicaScopus-id: 2-s2.0-85173287641
01
17An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine LevelsCoautor: Jung-Cook, Helgi, de Leon, Jose, Schoretsanitis, Georgios, Smith, Robert L., et al.2022PharmacopsychiatryWoS-id: 000730418000001
Scopus-id: 2-s2.0-85122150966
216241
18Erratum: Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels (Pharmacopsychiatry (2022) 55 2 (73-86))Coautor: Jung-Cook H., de Leon J., Schoretsanitis G., Smith R.L., et al.2022PharmacopsychiatryWoS-id: 000744640100001
Scopus-id: 2-s2.0-85126389175
42
19Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patientsCoautor: Jung, Helgi, Cardenas, Graciela, Chavez-Canales, Maria, Maria Espinosa, Ana, et al.2022TrialsWoS-id: 000755135500004
Scopus-id: 2-s2.0-85124579499
1111
20beta-cyclodextrin dendritic derivatives as permeation mediators to enhance the in vitro albendazole cysticidal activity by the improvement of the diffusion componentCoautor: Jung-Cook, Helgi, Jose Lopez-Mendez, Luis, Palomares-Alonso, Francisca, Gonzalez-Hernandez, Iliana, et al.2022RSC ADVANCESWoS-id: 000841907700001
Scopus-id: 2-s2.0-85137797149
23
21Historical Aspects of Herbal Use and Comparison of Current Regulations of Herbal Products between Mexico, Canada and the United States of America2ᵒ autor: Jung-Cook, Helgi, Rojas, Patricia, Ruiz-Sanchez, Elizabeth, Rojas-Tome, Irma Susana, et al.2022INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTHWoS-id: 000896252500001
Scopus-id: 2-s2.0-85143698269
1423
22Giardia duodenalis: Flavohemoglobin is involved in drug biotransformation and resistance to albendazoleCoautor: Jung-Cook H., Pech-Santiago E.O., Argüello-García R., Vázquez C., et al.2022PLOS PATHOGENSWoS-id: 000933370700002
Scopus-id: 2-s2.0-85139374519
1010
23Policy of Multisource Drug Products in Latin America: Opportunities and Challenges on the Application of Bioequivalence In Vitro AssaysCoautor: Jung-Cook H., Miranda-Pérez de Alejo C., Aceituno Álvarez A., Mendes Lima Santos G., et al.2021THERAPEUTIC INNOVATION & REGULATORY SCIENCEWoS-id: 000544133800001
Scopus-id: 2-s2.0-85087374455
27
24DEVELOPMENT OF A DISSOLUTION TEST FOR MELATONIN SUBLINGUAL TABLETS USING A FACTORIAL EXPERIMENTAL DESIGNCoautor y autor de correspondencia: Jung-Cook, Helgi, Mayet-Cruz, Lourdes, Manuel Rodriguez, Juan2021FarmaciaWoS-id: 000623961800023
Scopus-id: 2-s2.0-85102303847
66
25Amerindians may need clozapine dosing similar to that of Asians2ᵒ autor: Jung-Cook, Helgi, Gonzalez-Esquivel, Dinora F., Baptista, Trino, de Leon, Jose2021REVISTA DE PSIQUIATRIA Y SALUD MENTALWoS-id: 000684860000007
Scopus-id: 2-s2.0-85098187367
2224
26Nose-to-Brain Delivery of Dexamethasone: Biodistribution Studies in MiceCoautor: Jung-Cook, Helgi, Nicolas Perez-Osorio, Ivan, Espinosa, Alejandro, Giraldo Velazquez, Manuel, et al.2021JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSWoS-id: 000697368100006
Scopus-id: 2-s2.0-85116369467
1615
27Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital2ᵒ autor: Jung-Cook, Helgi, Fricke-Galindo, Ingrid, Martinez-Juarez, Iris E., Monroy-Jaramillo, Nancy, et al.2021PharmacogenomicsWoS-id: 000703916100001
Scopus-id: 2-s2.0-85117349986
22
28Effect of dexamethasone on albendazole cysticidal activity in experimental cysticercosis by Taenia crassiceps in BALB/c mice: In vitro and in vivo evaluationCoautor: Jung-Cook, Helgi, Palomares-Alonso, Francisca, Toledo, Andrea, Palencia Hernandez, Guadalupe, et al.2020EXPERIMENTAL PARASITOLOGYWoS-id: 000509424500007
Scopus-id: 2-s2.0-85075070482
1313
29Search for a heavy pseudoscalar Higgs boson decaying into a 125 GeV Higgs boson and a Z boson in final states with two tau and two light leptons at vs = 13 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000519448300001
Scopus-id: 2-s2.0-85081752688
3237
30Search for new neutral Higgs bosons through the H ? ZA? l+l-b b ¯ process in pp collisions at vs = 13 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000519956200001
Scopus-id: 2-s2.0-85081745907
552
31Measurement of top quark pair production in association with a Z boson in proton-proton collisions at vs = 13 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000519956200002
Scopus-id: 2-s2.0-85081715381
6197
32Search for physics beyond the standard model in multilepton final states in proton-proton collisions at vs = 13 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000519956400001
Scopus-id: 2-s2.0-85081750873
4062
33Search for lepton flavour violating decays of a neutral heavy Higgs boson to µt and et in proton-proton collisions at vs = 13 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000520831600001
Scopus-id: 2-s2.0-85082490831
2224
34Search for supersymmetry in pp collisions at s =13 TeV with 137 fb-1 in final states with a single lepton using the sum of masses of large-radius jetsCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020PHYSICAL REVIEW DWoS-id: 000522162000002
Scopus-id: 2-s2.0-85083578322
2733
35A search for the standard model Higgs boson decaying to charm quarksCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000522420200001
Scopus-id: 2-s2.0-85082571729
5048
36Search for a Narrow Resonance Lighter than 200 GeV Decaying to a Pair of Muons in Proton-Proton Collisions at s =13 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020PHYSICAL REVIEW LETTERSWoS-id: 000523412800003
Scopus-id: 2-s2.0-85083755554
76107
37Cysticidal activity of praziquantel-mebendazole combination: In vitro and in vivo studiesCoautor: Helgi J.-C., Francisca P.-A., Javier L.-M.F., Guadalupe P.H., et al.2020ACTA TROPICAWoS-id: 000525791600020
Scopus-id: 2-s2.0-85074710113
66
38Constraints on the ?c1 versus ?c2 Polarizations in Proton-Proton Collisions at s =8 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020PHYSICAL REVIEW LETTERSWoS-id: 000528518000007
Scopus-id: 2-s2.0-85084721870
1516
39Search for heavy Higgs bosons decaying to a top quark pair in proton-proton collisions at vs = 13 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000529541000001
Scopus-id: 2-s2.0-85085935293
22106
40Measurement of properties of Bs0 ? µ+µ- decays and search for B0 ? µ+µ- with the CMS experimentCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000529688900001
Scopus-id: 2-s2.0-85084126150
8087
41A multi-dimensional search for new heavy resonances decaying to boosted WW , WZ , or ZZ boson pairs in the dijet final state at 13 TeCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020EUROPEAN PHYSICAL JOURNAL CWoS-id: 000531858300007
Scopus-id: 2-s2.0-85081746798
3442
42Measurement of differential cross sections and charge ratios for t-channel single top quark production in proton?proton collisions at vs=13TeCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020EUROPEAN PHYSICAL JOURNAL CWoS-id: 000534232700010
Scopus-id: 2-s2.0-85084861861
338
43Search for an excited lepton that decays via a contact interaction to a lepton and two jets in proton-proton collisions at vs = 13 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000534520400001
Scopus-id: 2-s2.0-85084637829
1310
44Search for direct top squark pair production in events with one lepton, jets, and missing transverse momentum at 13 TeV with the CMS experimentCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000534779800001
Scopus-id: 2-s2.0-85084492726
5556
45Population Pharmacokinetics Of Levetiracetam In Mexican Adult Patients With EpilepsyCoautor: Helene Jung-Cook, Helgi, Patricia Hernandez-Mitre, Maria, Edith Medellin-Garibay, Susanna, Rodriguez-Leyva, Ildefonso, et al.2020NeurologyWoS-id: 000536058007274
00
46Population Pharmacokinetics and Dosing Recommendations of Levetiracetam in Adult and Elderly Patients With EpilepsyCoautor: Jung-Cook H.H., Hernández-Mitre M.P., Medellín-Garibay S.E., Rodriguez-Leyva, Ildefonso, et al.2020JOURNAL OF PHARMACEUTICAL SCIENCESWoS-id: 000536917400025
Scopus-id: 2-s2.0-85082533723
2123
47Influence of genetic variants and antiepileptic drug co-treatment on lamotrigine plasma concentration in Mexican Mestizo patients with epilepsyCoautor: Jung-Cook H., Ortega-Vázquez A., Fricke-Galindo I., Dorado P., et al.2020PHARMACOGENOMICS JOURNALWoS-id: 000537022300001
Scopus-id: 2-s2.0-85085899958
1213
48Measurement of the cross section for electroweak production of a Z boson, a photon and two jets in proton-proton collisions at vs = 13 TeV and constraints on anomalous quartic couplingsCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000540141000001
Scopus-id: 2-s2.0-85086388647
4755
49Search for dijet resonances using events with three jets in proton-proton collisions at s=13TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020PHYSICS LETTERS BWoS-id: 000541379800015
Scopus-id: 2-s2.0-85083832485
823
50A measurement of the Higgs boson mass in the diphoton decay channelCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020PHYSICS LETTERS BWoS-id: 000541379800028
Scopus-id: 2-s2.0-85083661454
122169
51Population pharmacokinetics of mycophenolic acid in adult kidney transplant patients under prednisone and tacrolimus regimenCoautor: Jung-Cook H., Reséndiz-Galván J.E., Romano-Aguilar M., Medellín-Garibay S.E., et al.2020EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESWoS-id: 000541459800002
Scopus-id: 2-s2.0-85084387984
1515
52Moringa oleifera Extracts and Praziquantel Combination: Bioavailability in Rats and Cysticidal Activity in a Murine Model2ᵒ autor: Jung, Helgi, Palomares-Alonso, Francisca, Vidal-Cantu, Guadalupe Concepcion, Rojas-Tome, Irma Susana, et al.2020REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSYWoS-id: 000541552800012
Scopus-id: 2-s2.0-85133706922
12
53Identification of heavy, energetic, hadronically decaying particles using machine-learning techniquesCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF INSTRUMENTATIONWoS-id: 000545350900005
Scopus-id: 2-s2.0-85088524436
122147
54Measurements with silicon photomultipliers of dose-rate effects in the radiation damage of plastic scintillator tiles in the CMS hadron endcap calorimeterCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF INSTRUMENTATIONWoS-id: 000545350900009
Scopus-id: 2-s2.0-85088533574
1212
55Measurement of quark- and gluon-like jet fractions using jet charge in PbPb and pp collisions at 5.02 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000550237400001
Scopus-id: 2-s2.0-85088976873
3028
56Assessment of lamivudine, zidovudine, lopinavir, and ritonavir plasma levels in HIV-positive pregnant women: Drug monitoring application to improve patient safety2ᵒ autor: Jung-Cook, Helgi Helene, Hernandez-Pineda, Jessica, Katende-Kyenda, Norah Lucky, Galindo-Sevilla, Norma, et al.2020MedicineWoS-id: 000551511100104
Scopus-id: 2-s2.0-85085677653
00
57Search for charged Higgs bosons decaying into a top and a bottom quark in the all-jet final state of pp collisions at vs = 13 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000552680600001
Scopus-id: 2-s2.0-85088646665
8076
58The production of isolated photons in PbPb and pp collisions at vsNN = 5.02 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000553357900001
Scopus-id: 2-s2.0-85088163145
1616
59Measurements of tt[over ¯]H Production and the CP Structure of the Yukawa Interaction between the Higgs Boson and Top Quark in the Diphoton Decay ChannelCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020PHYSICAL REVIEW LETTERSWoS-id: 000555785600002
Scopus-id: 2-s2.0-85089978062
95138
60Study of central exclusive [InlineEquation not available: see fulltext.] production in proton-proton collisions at vs=5.02 and 13TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020EUROPEAN PHYSICAL JOURNAL CWoS-id: 000561401400001
Scopus-id: 2-s2.0-85089197692
610
61Combination of the W boson polarization measurements in top quark decays using ATLAS and CMS data at vs = 8 TeVCoautor: Jung H., Aad G., Abbott B., Abbott D.C., et al.2020JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000562898300001
Scopus-id: 2-s2.0-85090035581
8440
62Search for a light pseudoscalar Higgs boson in the boosted µµtt final state in proton-proton collisions at vs = 13 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000563451600001
Scopus-id: 2-s2.0-85089987196
2746
63Search for physics beyond the standard model in events with jets and two same-sign or at least three charged leptons in proton-proton collisions at vs=13TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020EUROPEAN PHYSICAL JOURNAL CWoS-id: 000564267800004
Scopus-id: 2-s2.0-85089776333
4346
64Measurement of the Y(1S) pair production cross section and search for resonances decaying to Y(1S)µ+µ- in proton-proton collisions at s=13TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020PHYSICS LETTERS BWoS-id: 000571769700001
Scopus-id: 2-s2.0-85087979274
1868
65Measurement of CKM matrix elements in single top quark t-channel production in proton-proton collisions at s=13 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020PHYSICS LETTERS BWoS-id: 000571769700003
Scopus-id: 2-s2.0-85088271548
2029
66Preparation and Evaluation of Mebendazole Microemulsion for Intranasal Delivery: an Alternative Approach for Glioblastoma Treatment2ᵒ autor: Jung-Cook, Helgi, Mena-Hernandez, Julio, Llaguno-Munive, Monserrat, Garcia-Lopez, Patricia, et al.2020AAPS PHARMSCITECHWoS-id: 000572894700001
Scopus-id: 2-s2.0-85091489301
1415
67Logic of selecting suitable dissolution parameters in new drug formulations based on a BCS approachCoautor: Jung-Cook, Helgi, Medina-Lopez, Raul, Arregui, Edgar E., Aranda, Edson J., et al.2020IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCHWoS-id: 000574835400001
Scopus-id: 2-s2.0-85085287308
23
68Measurements of production cross sections of WZ and same-sign WW boson pairs in association with two jets in proton-proton collisions at s=13TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020PHYSICS LETTERS BWoS-id: 000581871500021
Scopus-id: 2-s2.0-85090038895
12093
69High prevalence of CYP2D6 ultrarapid metabolizers in a mestizo Colombian population in relation to Hispanic mestizo populationsCoautor: Jung-Cook, Helgi, Sarmiento, Alba P., Dorado, Pedro, Borbon, Angelica, et al.2020PharmacogenomicsWoS-id: 000584494200001
Scopus-id: 2-s2.0-85096947039
12
70Search for high mass dijet resonances with a new background prediction method in proton-proton collisions at vs = 13 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000613068100001
Scopus-id: 2-s2.0-85084474401
145169
71Study of J/? meson production inside jets in pp collisions at s=8TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2020PHYSICS LETTERS BWoS-id: 000613068800001
Scopus-id: 2-s2.0-85082850250
1519
72Factors Associated With Cysticidal Treatment Response in Extraparenchymal NeurocysticercosisCoautor: Jung, Helgi, Osorio, Rocio, Carrillo-Mezo, Roger, Romo, Matthew L., et al.2019JOURNAL OF CLINICAL PHARMACOLOGYWoS-id: 000461573300010
Scopus-id: 2-s2.0-85057560245
3031
73Pharmaceutical Evaluation And Therapeutic Drug Monitoring Of Levetiracetam In Patients With EpilepsyCoautor: Jung Cook, Helgi Helene, Hernandez Mitre, Maria Patricia, Rodriguez Leyva, Ildefonso, Castillo Ibarra, Herlinda, et al.2019NeurologyWoS-id: 000475965903050
00
74Evaluation of New Benzimidazole Derivatives as Cysticidal Agents: In Vitro, in Vivo and Docking StudiesCoautor: Jung-Cook, Helgi, Gonzalez-Hernandez, Iliana, Palomares-Alonso, Francisca, Becerril-Vega, Jose, et al.2019CHEMICAL & PHARMACEUTICAL BULLETINWoS-id: 000500080400005
Scopus-id: 2-s2.0-85075931757
13
75Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis PatientsCoautor: Jung-Cook H., de la Fuente-Sandoval C., Reyes-Madrigal F., Mao X., et al.2018BIOLOGICAL PSYCHIATRYWoS-id: 000424667200005
Scopus-id: 2-s2.0-85033588199
6665
76Search for pair production of vector-like quarks in the bWbâ?¾W channel from protonâ??proton collisions at s=13TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2018PHYSICS LETTERS BWoS-id: 000429098900011
Scopus-id: 2-s2.0-85047566165
7580
77Observation of the Higgs boson decay to a pair of Ï? leptons with the CMS detectorCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2018PHYSICS LETTERS BWoS-id: 000429098900036
Scopus-id: 2-s2.0-85047666573
197221
78Pharmacogenetics of adverse reactions to antiepileptic drugs2ᵒ autor: Jung-Cook H., Fricke-Galindo I., LLerena A., López-López M.2018NeurologiaWoS-id: 000429222300004
Scopus-id: 2-s2.0-85043720784
3441
79Carbamazepine adverse drug reactionsCoautor: Jung-Cook, Helgi, Fricke-Galindo, Ingrid, LLerena, Adrian, Lopez-Lopez, Marisol2018EXPERT REVIEW OF CLINICAL PHARMACOLOGYWoS-id: 000440067200006
Scopus-id: 2-s2.0-85051315295
6484
80PK/PD of rac-Ibuprofen Co-administered with Caffeine: a Preclinical Study Using PIFIR ModelCoautor: Jung, Helgi, Medina, Raul, Hurtado, Marcela, Soria-Arteche, Olivia, et al.2018LATIN AMERICAN JOURNAL OF PHARMACYWoS-id: 000444257100024
Scopus-id: 2-s2.0-85054140394
11
81Interethnic variability in CYP2D6, CYP2C9, and CYP2C19 genes and predicted drug metabolism phenotypes among 6060 ibero-and native Americans: RIBEF-CEIBA consortium report on population pharmacogenomicsCoautor: Jung-Cook H., Naranjo M.-E.G., Rodrigues-Soares F., Peñas-Lledó E.M., et al.2018OMICSWoS-id: 000444386700001
Scopus-id: 2-s2.0-85053861167
3441
82Comparative in vitro dissolution and in vivo bioavailability of commercial amlodipine tablets1ᵉʳ autor: Jung-Cook, Helgi, Mayet-Cruz, Lourdes, Elena Girard-Cuesy, Maria2018TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCHWoS-id: 000445915100001
Scopus-id: 2-s2.0-85054542467
65
83Observation of Medium-Induced Modifications of Jet Fragmentation in Pb-Pb Collisions at sNN =5.02 TeV Using Isolated Photon-Tagged JetsCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2018PHYSICAL REVIEW LETTERSWoS-id: 000453476900007
Scopus-id: 2-s2.0-85059112614
3859
84Angular analysis of the decay B+ ?k+µ+µ- in proton-proton collisions at s =8 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2018PHYSICAL REVIEW DWoS-id: 000454168500003
Scopus-id: 2-s2.0-85059477183
3445
85Search for pair-produced resonances decaying to quark pairs in proton-proton collisions at s =13 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2018PHYSICAL REVIEW DWoS-id: 000454634400001
Scopus-id: 2-s2.0-85059460372
3253
86Full validation of curcumin analytical method by LC-MS/MS points out that the degree of hemolysis in plasma affects the quantitation: application in dog plasma studyCoautor: Jung, Helgi, Dolores, Mariana, Villaseñor A., Revilla Váquez A.L., et al.2018Journal Of The Mexican Chemical SocietyWoS-id: 000496747300005
Scopus-id: 2-s2.0-85073279799
11
87Novel triclabendazole prodrug: A highly water soluble alternative for the treatment of fasciolosisCoautor: Jung-Cook, Helgi, Flores-Ramos, Miguel, Ibarra-Velarde, Froylan, Hernandez-Campos, Alicia, et al.2017BIOORGANIC & MEDICINAL CHEMISTRY LETTERSWoS-id: 000392900600047
Scopus-id: 2-s2.0-85008219689
2931
88Effect of nitazoxanide on albendazole pharmacokinetics in cerebrospinal fluid and plasma in ratsCoautor: Jung-Cook, Helgi, Ruiz-Olmedo, M.I., Gonzalez-Hernandez, Iliana, Palomares-Alonso, Francisca, et al.2017SAUDI PHARMACEUTICAL JOURNALWoS-id: 000397040900015
Scopus-id: 2-s2.0-85001840590
88
89In vitro and in vivo cysticidal activity of extracts and isolated flavanone from the bark of Prunus serotina: A bio-guided studyCoautor: Jung-Cook, Helgi, Palomares-Alonso, Francisca, Susana Rojas-Tome, Irma, Palencia Hernandez, Guadalupe, et al.2017ACTA TROPICAWoS-id: 000401600300001
Scopus-id: 2-s2.0-85013799851
911
90Biowaiver Evidence for Ketorolac Tromethamine Immediate-Release Tablets1ᵉʳ autor: Jung-Cook, Helgi, Mayet-Cruz, Lourdes, Rubio-Carrasco, Kenneth, Girard-Cuesy, Maria E.2017LATIN AMERICAN JOURNAL OF PHARMACYWoS-id: 000406050300017
Scopus-id: 2-s2.0-85019864773
11
91Measurement of charged pion, kaon, and proton production in proton-proton collisions at vs = 13 TeVCoautor: Jung H., Sirunyan A.M., Tumasyan A., Adam W., et al.2017PHYSICAL REVIEW DWoS-id: 000417077700002
Scopus-id: 2-s2.0-85049393881
5867
92Synthesis and solubility determination of a highly water soluble phosphonooxymethyl prodrugCoautor: Jung-Cook, Helgi, Castillo-Bocanegra, Rafael, Victoria-Miguel, Jorge, Hernandez Campos, Alicia2017Abstracts Of Papers Of The American Chemical SocietyWoS-id: 000430569104736
00
93Simple and rapid determination of ibuprofen without caffeine interference by HPLC-UV detection: Application to pharmacokinetic studies in rats2ᵒ autor: Jung H., Medina J.R., Hurtado M., Soria O., et al.2017International Journal of Research in Pharmaceutical SciencesScopus-id: 2-s2.0-85019050307
05
94Chiral Resolution of RS-Praziquantel via Diastereomeric Co-Crystal Pair Formation with l -Malic AcidCoautor: Jung-Cook, Helgi, Sanchez-Guadarrama, Obdulia, Mendoza-Navarro, Fabiola, Cedillo-Cruz, Alberto, et al.2016CRYSTAL GROWTH & DESIGNWoS-id: 000367963400033
Scopus-id: 2-s2.0-84954061898
6975
95Comparison of a high-performance liquid chromatography method for quantification of carbamazepine with chemiluminescent microparticle immunoassayCoautor: Jung Cook, Helgi, Guerrero Garduno, Oscar, Gonzalez-Esquivel, Dinora F., Escalante-Membrillo, Carmen, et al.2016BIOMEDICAL CHROMATOGRAPHYWoS-id: 000375863500018
Scopus-id: 2-s2.0-84948845478
1615
96CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsyCoautor: Jung-Cook, H., Ortega-Vazquez, A., Dorado, P., Fricke-Galindo, I., et al.2016PHARMACOGENOMICS JOURNALWoS-id: 000376195000010
Scopus-id: 2-s2.0-84934343834
2626
97Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican populationCoautor: Jung-Cook H., Céspedes-Garro C., Rodrigues-Soares F., Jiménez-Arce G., et al.2016REVISTA DE BIOLOGIA TROPICALWoS-id: 000383467900012
Scopus-id: 2-s2.0-84978983285
912
98In vivo anticoccidial activity of quinfamide in broilers: a preliminary reportCoautor: Jung, Helgi, Aquino, Itzcoatl, Alcala, Yazmin, Gutierrez, Lilia, et al.2016ITALIAN JOURNAL OF ANIMAL SCIENCEWoS-id: 000388956000018
Scopus-id: 2-s2.0-84996599516
10
99Characterization and comparability of biosimilars: A filgrastim case of study and regulatory perspectives for Latin AmericaCoautor: Jung-Cook, Helgi, Mendoza-Macedo, Karina, Romero-Diaz, Alexis J., Miranda-Hernandez, Mariana P., et al.2016Electronic Journal Of BiotechnologyWoS-id: 000389595400011
Scopus-id: 2-s2.0-84995602256
1312
100Pharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in Latin AmericaCoautor: Jung-Cook, Helgi, Sosa-Macias, Martha, Teran, Enrique, Waters, William, et al.2016PharmacogenomicsWoS-id: 000391865500002
Scopus-id: 2-s2.0-84995610460
1618
101Allele and genotype frequencies of genes relevant to anti-epileptic drug therapy in Mexican-Mestizo healthy volunteersCoautor: Jung-Cook, Helgi, Fricke-Galindo, Ingrid, Ortega-Vazquez, Alberto, Monroy-Jaramillo, Nancy, et al.2016PharmacogenomicsWoS-id: 000391865800007
Scopus-id: 2-s2.0-84995427113
1113
102Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: A report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics)2ᵒ autor: Jung-Cook H., Fricke-Galindo I., Llerena A., López-López M.2016Drug Metabolism and Personalized TherapyScopus-id: 2-s2.0-84974667688
020
103Production of inclusive ?(1S) and ?(2S) in p?Pb collisions at vs NN =5.02 TeVCoautor: Jung, H, Abelev, B, Adam, J, Adamova, D, et al.2015PHYSICS LETTERS BWoS-id: 000347046200016
Scopus-id: 2-s2.0-85040584200
7584
104Multiplicity dependence of jet-like two-particle correlation structures in p-Pb collisions at sNN=5.02 TeVCoautor: Jung, H, Abelev, B, Adam, J, Adamova, D, et al.2015PHYSICS LETTERS BWoS-id: 000348290800003
Scopus-id: 2-s2.0-84919897635
3737
105Measurement of electrons from semileptonic heavy-flavor hadron decays in pp collisions at s =2.76TeVCoautor: Jung, H, Abelev, B, Adam, J, Adamova, D, et al.2015PHYSICAL REVIEW DWoS-id: 000348570000001
Scopus-id: 2-s2.0-84920896786
2530
106Production of S(1385) ± and ?(1530) 0 in proton?proton collisions at vs = 7 TeVCoautor: Jung, H, Abelev, B, Adam, J, Adamova, D, et al.2015EUROPEAN PHYSICAL JOURNAL CWoS-id: 000348990800001
Scopus-id: 2-s2.0-84920990107
5985
107Murine cysticercosis model: Influence of the infection time and the time of treatment on the cysticidal efficacy of albendazole and praziquantelCoautor: Jung-Cook H., Palomares-Alonso F., Hernandez, GP, Rojas-Tomé I.S., et al.2015EXPERIMENTAL PARASITOLOGYWoS-id: 000349202700001
Scopus-id: 2-s2.0-84921287612
1315
108Hypothyroidism in multiple sclerosis patient during fingolimod treatmentCoautor: Jung H., Flores J., Rito Y., Torres G., et al.2015JOURNAL OF THE NEUROLOGICAL SCIENCESWoS-id: 000349588300045
Scopus-id: 2-s2.0-84921054847
44
109Influence of quinacrine and chloroquine on the in vitro 3'-azido-3'-deoxythymidine antiretroviral effectCoautor: Jung-Cook H., Torres K.J., Reyes-Terán G., Sotelo J., et al.2015AIDS RESEARCH AND THERAPYWoS-id: 000351200500001
Scopus-id: 2-s2.0-84928724804
12
110K*(892)0 and f(1020) production in Pb-Pb collisions at sNN =2.76 TeVCoautor: Jung, H, Abelev, B, Adam, J, Adamova, D, et al.2015PHYSICAL REVIEW CWoS-id: 000352303500007
Scopus-id: 2-s2.0-84923309372
215254
111Two-pion femtoscopy in p -Pb collisions at sNN =5.02 TeVCoautor: Jung, H, Adam, J, Adamova, D, Aggarwal, MM, et al.2015PHYSICAL REVIEW CWoS-id: 000353911600006
Scopus-id: 2-s2.0-84961288805
5968
112Measurement of jet suppression in central Pb?Pb collisions at vs NN =2.76 TeVCoautor: Jung, H, Adam, J, Adamova, D, Aggarwal, MM, et al.2015PHYSICS LETTERS BWoS-id: 000355378200001
Scopus-id: 2-s2.0-85040565135
136152
113Measurement of dijet k T in p?Pb collisions at vs NN =5.02 TeVCoautor: Jung, H, Adam, J, Adamova, D, Aggarwal, MM, et al.2015PHYSICS LETTERS BWoS-id: 000355378200063
Scopus-id: 2-s2.0-85040560156
2724
114Inclusive photon production at forward rapidities in proton?proton collisions at vs = 0.9, 2.76 and 7 TeVCoautor: Jung, H, Abelev, B, Adam, J, Adamova, D, et al.2015EUROPEAN PHYSICAL JOURNAL CWoS-id: 000355669300005
Scopus-id: 2-s2.0-84928034384
1817
115Measurement of pion, kaon and proton production in proton?proton collisions at vs = 7 TeVCoautor: Jung, H, Adam, J, Adamova, D, Aggarwal, MM, et al.2015EUROPEAN PHYSICAL JOURNAL CWoS-id: 000355680900002
Scopus-id: 2-s2.0-84930211632
154170
116Centrality dependence of particle production in p-Pb collisions at s NN =5.02 TeVCoautor: Jung, H, Adam, J, Adamova, D, Aggarwal, MM, et al.2015PHYSICAL REVIEW CWoS-id: 000355721900004
Scopus-id: 2-s2.0-84935844751
214214
117Forward-backward multiplicity correlations in pp collisions at vs = 0.9, 2.76 and 7 TeVCoautor: Jung, H, Adam, J, Adamova, D, Aggarwal, MM, et al.2015JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000355949100001
Scopus-id: 2-s2.0-84930225537
3425
118Rapidity and transverse-momentum dependence of the inclusive J/? nuclear modification factor in p-Pb collisions at v sNN = 5.02 TeVCoautor: Jung, H, Adam, J, Adamova, D, Adamova, D, et al.2015JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000356156900001
Scopus-id: 2-s2.0-84931266404
8254
119Charged jet cross sections and properties in proton-proton collisions at s = 7 TeVCoautor: Jung, H, Abelev, B, Adam, J, Adamova, D, et al.2015PHYSICAL REVIEW DWoS-id: 000356583000001
Scopus-id: 2-s2.0-84936754691
3459
120Elliptic flow of identified hadrons in Pb-Pb collisions at (Formula presented.) = 2.76 TeVCoautor: Jung, H, Abelev, B, Adam, J, Adamova, D, et al.2015JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000357725800001
Scopus-id: 2-s2.0-84937566359
205137
121Inclusive, prompt and non-prompt J/? production at mid-rapidity in Pb-Pb collisions at vsNN TeVCoautor: Jung, H, Adam, J, Adamova, D, Aggarwal, MM, et al.2015JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000357931400001
Scopus-id: 2-s2.0-84938834279
6649
122Cysticidal activity of extracts and isolated compounds from Teloxys graveolens: In vitro and in vivo studiesCoautor: JungCook, H, PalomaresAlonso, F, RojasTome, IS, Rocha, VJ, et al.2015EXPERIMENTAL PARASITOLOGYWoS-id: 000360323400011
Scopus-id: 2-s2.0-84934945023
710
123Measurement of charged jet production cross sections and nuclear modification in p?Pb collisions at vs NN =5.02 TeVCoautor: Jung, H, Adam, J, Adamova, D, Aggarwal, MM, et al.2015PHYSICS LETTERS BWoS-id: 000361562900009
Scopus-id: 2-s2.0-85040596149
6972
124Measurement of charm and beauty production at central rapidity versus charged-particle multiplicity in proton-proton collisions at vs = 7 TeVCoautor: Jung, H, Adam, J, Adamova, D, Aggarwal, MM, et al.2015JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000362024600001
Scopus-id: 2-s2.0-84942886883
8963
125Precision measurement of the mass difference between light nuclei and anti-nucleiCoautor: Jung, H, Adam, J, Adamova, D, Adamova, D, et al.2015NATURE PHYSICSWoS-id: 000362188600013
Scopus-id: 2-s2.0-84943198109
5259
126Measurement of jet quenching with semi-inclusive hadron-jet distributions in central Pb-Pb collisions at vsNN = 2.76 TeVCoautor: Jung, H, Adam, J, Adamova, D, Aggarwal, MM, et al.2015JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000362274600001
Scopus-id: 2-s2.0-84943167400
11788
127Coherent ?0 photoproduction in ultra-peripheral Pb-Pb collisions at vsNN=2.76 TeVCoautor: Jung, H, Adam, J, Adamova, D, Aggarwal, MM, et al.2015JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000363539300001
Scopus-id: 2-s2.0-84942575935
5146
128One-dimensional pion, kaon, and proton femtoscopy in Pb-Pb collisions at s NN =2.76 TeVCoautor: Jung, H, Adam, J, Adamova, D, Aggarwal, MM, et al.2015PHYSICAL REVIEW CWoS-id: 000364998600002
Scopus-id: 2-s2.0-84948675616
7580
129Coherent ?(2S) photo-production in ultra-peripheral Pb?Pb collisions at vs NN =2.76 TeVCoautor: Jung, H, Adam, J, Adamova, D, Aggarwal, MM, et al.2015PHYSICS LETTERS BWoS-id: 000365384600059
Scopus-id: 2-s2.0-85041283233
4344
130Centrality dependence of high-p T D meson suppression in Pb-Pb collisions at (Formula presented.) TeVCoautor: Jung, H, Adam, J, Adamova, D, Aggarwar, MM, et al.2015JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000366380600001
Scopus-id: 2-s2.0-84949566305
6035
131Centrality dependence of inclusive J/? production in p-Pb collisions at (Formula presented.) TeVCoautor: Jung, H, Adam, J, Adamova, D, Aggarwal, M, et al.2015JOURNAL OF HIGH ENERGY PHYSICSWoS-id: 000366382400001
Scopus-id: 2-s2.0-84949555773
5428
132Highly water-soluble benzimidazole derivatives useful for the treatment of fasciolosisCoautor: Jung-Cook, Helgi, Castillo-Bocanegra, Rafael, Flores-Ramos, Miguel, Ibarra, Froylan, et al.2015Abstracts Of Papers Of The American Chemical SocietyWoS-id: 000432475701205
00
133Distribution of hydroxychloroquine in lymphoid tissue in a rabbit model for HIV infectionCoautor: Jung-Cook H., González-Hernández I., Aguirre-Cruz L., Sotelo, J, et al.2014ANTIMICROBIAL AGENTS AND CHEMOTHERAPYWoS-id: 000329581100076
Scopus-id: 2-s2.0-84891524416
89
134A straightforward and efficient synthesis of praziquantel enantiomers and their 4'-hydroxy derivativesCoautor: Jung-Cook, H, Cedillo-Cruz, A, Aguilar, MI, Flores-Alamo, M, et al.2014TETRAHEDRON-ASYMMETRYWoS-id: 000331684700005
Scopus-id: 2-s2.0-84893110277
2225
135A highly water soluble benzimidazole derivative useful for the treatment of fasciolosisCoautor: Jung-Cook H., Flores-Ramos M., Ibarra-Velarde F., Hernández-Campos A., et al.2014BIOORGANIC & MEDICINAL CHEMISTRY LETTERSWoS-id: 000345581300055
Scopus-id: 2-s2.0-84911925659
1717
136HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patientsCoautor: Jung-Cook H., Fricke-Galindo I., Martínez-Juárez I.E., Monroy-Jaramillo N., et al.2014PharmacogenomicsWoS-id: 000346235400005
Scopus-id: 2-s2.0-84919788263
3953
137Pharmacogenetic potential biomarkers for carbamazepine adverse drug reactions and clinical responseCoautor: Cook H.J., Jaramillo N.M., Galindo I.F., Vázquez A.O., et al.2014Drug Metabolism and Drug InteractionsScopus-id: 2-s2.0-84904208935
022
138Population pharmacokinetics of rifampicin in Mexican patients with tuberculosisCoautor: Cook, HJ, Segovia, RCM, Ramirez, AMD, Aquino, MM, et al.2013Journal Of Clinical Pharmacy And TherapeuticsWoS-id: 000312991500011
Scopus-id: 2-s2.0-84871990412
2930
139(S)-(+)-cis-4'-BenzyloxypraziquantelCoautor y autor de correspondencia: Jung-Cook H., Cedillo-Cruz A., Aguilar M.I.2013ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINEScopus-id: 2-s2.0-84889664137
02
140Biopharmaceutics in Mexico. A brief analysis of the past and present [La Biofarmacia en México. Un breve análisis del pasado y presente]1ᵉʳ autor y autor de correspondencia: Jung Cook H.2013Revista Mexicana de Ciencias FarmaceuticasScopus-id: 2-s2.0-84902826946
00
141Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis1ᵉʳ autor y autor de correspondencia: Jung-Cook H.2012EXPERT REVIEW OF CLINICAL PHARMACOLOGYWoS-id: 000209287500011
Scopus-id: 2-s2.0-83055163334
2325
142A simple LC-MS/MS method to determine plasma and cerebrospinal fluid levels of albendazole metabolites (albendazole sulfoxide and albendazole sulfone) in patients with neurocystCoautor: Jung-Cook H., González-Hernández I., Ruiz-Olmedo M.I., Cárdenas G.2012BIOMEDICAL CHROMATOGRAPHYWoS-id: 000298840300020
Scopus-id: 2-s2.0-84855449003
2223
143Comparison of dissolution profiles. Impact of criteria of different regulatory agencies on f2 calculation [Comparación de perfiles de disolución. Impacto de los criterios de diferentes agencias regulatorias en el cálculo de f2]1ᵉʳ autor: Jung Cook H., de Anda Jáuregui G., Rubio Carrasco K., Mayet Cruz L.2012Revista Mexicana de Ciencias FarmaceuticasScopus-id: 2-s2.0-84877642766
02
144Plasma levels of clozapine and norclozapine in Mexican schizophrenia patientsCoautor: Jung-Cook H., González-Esquivel D.F., Castro N., Ramírez-Bermúdez J., et al.2011ARZNEIMITTEL-FORSCHWoS-id: 000292536500002
Scopus-id: 2-s2.0-79960349923
1616
145Pharmacogenetics of the antiepileptic drugs phenytoin and lamotrigineCoautor: Jung-Cook H., López M., Dorado P., Monroy N., et al.2011Drug Metabolism and Drug InteractionsScopus-id: 2-s2.0-79956340310
027
146Monitoreo de las concentraciones plasmáticas de clozapina en pacientes con esquizofreniaCoautor: Jung-Cook H., Salazar-Pereyra A., Tomé I.S.R., Ramírez-Bermúdez J., et al.2011Archivos de NeurocienciasScopus-id: 2-s2.0-84887467154
02
147Two novel ternary albendazole-cyclodextrin-polymer systems: Dissolution, bioavailability and efficacy against Taenia crassiceps cystsCoautor: Jung-Cook H., Palomares-Alonso F., González C.R., Bernad-Bernad, MJ, et al.2010ACTA TROPICAWoS-id: 000272916100010
Scopus-id: 2-s2.0-71549138754
3238
148Therapeutic Re-188-lanreotide: determination of radiopharmacokinetic parameters in ratsCoautor: Jung-Cook H., Molina-Trinidad E.M., De Murphy C.A., Stack E.M., et al.2010JOURNAL OF PHARMACY AND PHARMACOLOGYWoS-id: 000277102200007
Scopus-id: 2-s2.0-77952859321
73
149Relative bioavailability of rifampicin in a three-drug fixed-dose combination formulationCoautor: Jung-Cook H., Milan-Segovia, RC, Domínguez-Ramírez A.M., Magana-Aquino, M, et al.2010INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASEWoS-id: 000283830500016
Scopus-id: 2-s2.0-78049449334
3333
150Pharmacokinetic behavior in sheep and cattle of 5-chloro-2-(methylthio)-6-(1-naphthyloxy)-1H-benzimidazole, a new fasciolicide agentCoautor: Jung-Cook H., RamÍrez N., Mayet L., Del Rivero L., et al.2009JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICSWoS-id: 000263966800007
Scopus-id: 2-s2.0-61849094372
913
151Synthesis and in vitro cysticidal activity of new benzimidazole derivatives2ᵒ autor: Jung-Cook H., Palomares-Alonso F., Pérez-Villanueva J., Piliado J.C., et al.2009EUROPEAN JOURNAL OF MEDICINAL CHEMISTRYWoS-id: 000264920000050
Scopus-id: 2-s2.0-61349184552
2937
152Sensitive high performance liquid chromatographic assay for nitazoxanide metabolite in plasmaCoautor: Jung-Cook H., Ruiz-Olmedo M.I., Gallegos-Perez J.L., Calderon-Gonzalez K.G., et al.2009PharmazieWoS-id: 000269341800001
Scopus-id: 2-s2.0-70349232761
1212
153Population pharmacokinetics of albendazole in patients with neurocysticercosisCoautor: Jung, H, Castro, N, Marquez-Caraveo, C, Brundage, RC, et al.2009INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICSWoS-id: 000272290500005
Scopus-id: 2-s2.0-70449379963
2024
154Medical treatment for neurocysticercosis: Drugs, indications and perspectives1ᵉʳ autor: Jung H., Cárdenas G., Sciutto E., Fleury A.2008CURRENT TOPICS IN MEDICINAL CHEMISTRYWoS-id: 000254078500009
Scopus-id: 2-s2.0-44849143205
2426
155Effect of malnutrition on the pharmacokinetics of cefuroxime axetil in young rats2ᵒ autor: Jung-Cook, H, Gonzalez-Hernandez, I, Sotelo, A2008JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCESWoS-id: 000259720900002
Scopus-id: 2-s2.0-53549101664
1010
156Comparative study on the dissolution profiles of commercial albendazole tablets [Estudio comparativo de perfiles de disolución de tabletas de albendazol del mercado nacional]2ᵒ autor: Jung-Cook H., Mayet C. L., Mendoza A. O., Rodríguez J.M.2008Revista Mexicana de Ciencias FarmaceuticasScopus-id: 2-s2.0-67649639626
04
157Measurement and QCD analysis of neutral and charged current cross sections at HERACoautor: Jung H., Adloff C., Andreev V., Andrieu B., et al.2003EUROPEAN PHYSICAL JOURNAL CWoS-id: 000185742000001
Scopus-id: 2-s2.0-1242311986
252280
158Quinfamide disposition in humans: Preliminary report [Disposicion de quinfamida en humanos: Estudio preliminar]2ᵒ autor: Jung C.H., Morales H.J.M., Barreda A.1999Investigación médica internacionalScopus-id: 2-s2.0-0033404235
01
159In vitro metabolic interaction between praziquantel and dexamethasoneCoautor: Jung Cook H., Gonzalez-Esquivel D.F., Sanchez Rodriguez M., Sotelo Morales J.1994Pharmacology CommunicationsScopus-id: 2-s2.0-0028115075
03
160Sensitive high-performance liquid chromatographic assay for praziquantel in plasma, urine and liver homogenatesCoautor: Jung Cook H., González-Esquivel D.F., Morano Okuno C., Sánchez Rodríguez M., et al.1993J CHROMATOGR BWoS-id: A1993KR54500024
Scopus-id: 2-s2.0-0027459288
1522
161Spirostanic diosgenin precursors from Dioscorea composita tubersCoautor: Jung H., Espejo O., Llavot J.C., Giral F.1982PhytochemistryWoS-id: A1982NE65600033
Scopus-id: 2-s2.0-0001194052
7574
Descargar PDF

Documentos no indexados (Humanindex)

# Título del documento ISSN Revista Año Fuente
Descargar PDF

No se encuentran registros en la base de datos de capítulos de libros (WoS y Scopus).

Descargar PDF

Obras con ISBN (Indautor)

# Título del documento Autores Alcance Año ISBN Fuente
1Problemas De BiofarmaciaJung Cook, Helgi Helene, Fuentes Noriega, Inés, Cañas Alonso, Roberto Carlos, et al.Libro Completo20219786073049665INDAUTOR
Descargar PDF

Proyectos

# Nombre Participantes Convocatoria Fecha Inicio Fecha Fin
1Preparación, caracterización fisicoquímica y evaluación in vivo de microemulsiones de mebendazol para administración nasalHELGI HELENE GISELA FRANZISKA JUNG COOK,
Recursos PAPIIT01-01-201731-12-2018
2Desarrollo de métodos con capacidad discriminatoria para evaluar la disolución de productos de liberación inmediata en presentación cápsulas de gelatina blanda o suspensión.HELGI HELENE GISELA FRANZISKA JUNG COOK,
Recursos PAPIIT01-01-201931-12-2020
3Síntesis, caracterización y estudio farmacocinético de nuevas formulaciones de albendazol para administración parenteralHELGI HELENE GISELA FRANZISKA JUNG COOK,
Recursos PAPIIT01-01-202231-12-2023
Descargar PDF

Participación en Comités de Tesis

# Título del documento Tipo de Tesis Sinodales Autores Año Entidad Url
1Evaluación de perfiles de disolución de productos conteniendo albendazol en suspensiónTesis de LicenciaturaHELGI HELENE GISELA FRANZISKA JUNG COOK; Sánchez Galicia, Luz Angélica; 2022Facultad de Química,
2Estudios clínicos de fármacos en combinación para el tratamiento de glioblastoma : una revisiónTesis de LicenciaturaHELGI HELENE GISELA FRANZISKA JUNG COOK; López Coca, Lizbeth; 2022Facultad de Química,
Descargar PDF

Docencia Impartida

# Entidad Nivel Asignatura Año Semestre Alumnos
1Facultad de QuímicaLicenciaturaBIOFARMACIA20252025-261
2Facultad de QuímicaLicenciaturaBIOFARMACIA20242025-158
3Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20242024-265
4Facultad de QuímicaLicenciaturaBIOFARMACIA20242024-259
5Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20232024-175
6Facultad de QuímicaLicenciaturaBIOFARMACIA20232024-158
7Facultad de QuímicaLicenciaturaBIOFARMACIA20232023-268
8Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20232023-254
9Facultad de QuímicaLicenciaturaBIOFARMACIA20222023-155
10Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20222023-162
11Facultad de QuímicaLicenciaturaBIOFARMACIA20222022-253
12Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20222022-261
13Facultad de QuímicaLicenciaturaBIOFARMACIA20212022-160
14Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20212022-147
15Facultad de QuímicaLicenciaturaBIOFARMACIA20212021-263
16Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20212021-265
17Facultad de QuímicaLicenciaturaBIOFARMACIA20202021-162
18Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20202021-157
19Facultad de QuímicaLicenciaturaBIOFARMACIA20202020-248
20Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20202020-264
21Facultad de QuímicaLicenciaturaBIOFARMACIA20192020-156
22Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20192020-146
23Facultad de QuímicaLicenciaturaBIOFARMACIA20192019-250
24Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20192019-257
25Facultad de QuímicaLicenciaturaBIOFARMACIA20182019-153
26Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20182019-147
27Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20182018-21
28Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20182018-254
29Facultad de QuímicaLicenciaturaBIOFARMACIA20182018-255
30Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20182018-21
31Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20182018-21
32Facultad de QuímicaMaestríaTEMA SELECTO,TEMAS SELECTOS DE BIOFARMACIA20172018-18
33Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20172018-11
34Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20172018-11
35Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20172018-11
36Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20172018-151
37Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20172017-254
38Facultad de QuímicaLicenciaturaBIOFARMACIA20172017-253
39Facultad de QuímicaLicenciaturaBIOFARMACIA20162017-150
40Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20162017-11
41Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20162017-11
42Facultad de QuímicaMaestríaTEMA SELECTO20162017-17
43Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20162017-145
44Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20162016-21
45Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20162016-256
46Facultad de QuímicaLicenciaturaBIOFARMACIA20162016-252
47Facultad de QuímicaLicenciaturaBIOFARMACIA20152016-155
48Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20152016-11
49Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20152016-11
50Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20152016-156
51Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20152015-21
52Facultad de QuímicaMaestríaTEMA SELECTO20152015-26
53Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20152015-21
54Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20152015-21
55Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20152015-21
56Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20152015-21
57Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20152015-261
58Facultad de QuímicaLicenciaturaBIOFARMACIA20152015-254
59Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20142015-151
60Facultad de QuímicaLicenciaturaBIOFARMACIA20142015-157
61Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20142015-11
62Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20142015-11
63Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20142015-11
64Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20142015-11
65Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20142015-11
66Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20142015-11
67Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20142014-21
68Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20142014-21
69Facultad de QuímicaMaestríaTEMA SELECTO20142014-26
70Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20142014-21
71Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20142014-264
72Facultad de QuímicaLicenciaturaBIOFARMACIA20142014-251
73Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20132014-157
74Facultad de QuímicaLicenciaturaBIOFARMACIA20132014-158
75Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20132014-11
76Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20132014-11
77Facultad de QuímicaMaestríaTRABAJO DE INVESTIGACION20132014-11
78Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20132013-256
79Facultad de QuímicaLicenciaturaBIOFARMACIA20132013-248
80Facultad de QuímicaLicenciaturaBIOFARMACIA20122013-155
81Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20122013-150
82Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20122012-250
83Facultad de QuímicaLicenciaturaBIOFARMACIA20122012-247
84Facultad de QuímicaMaestríaFARMACOCINETICA I (SISTEMA LADME, MODELOS COMPARTAMENTALES Y NO COMPARTAMENTALES)20122012-29
85Facultad de QuímicaMaestríaBIOFARMACIA I (SEPARACION Y PURIFICACION EN MUESTRAS BIOLOGICAS)20112012-12
86Facultad de MedicinaMaestríaSEMINARIO DE TEMAS SELECTOS20112012-12
87Facultad de MedicinaMaestríaMONITOREO TERAPEUTICO DE FARMACOS20112012-18
88Facultad de QuímicaLicenciaturaBIOFARMACIA20112012-151
89Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20112012-156
90Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20112011-265
91Facultad de QuímicaLicenciaturaBIOFARMACIA20112011-256
92Facultad de QuímicaMaestríaTEMAS SELECTOS20102011-110
93Facultad de QuímicaLicenciaturaBIOFARMACIA20102010-249
94Facultad de QuímicaLicenciaturaBIOFARMACIA20102010-21
95Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20102010-263
96Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20092010-144
97Facultad de QuímicaLicenciaturaBIOFARMACIA20092010-149
98Facultad de QuímicaMaestríaTEMAS SELECTOS20092010-16
99Facultad de QuímicaLicenciaturaBIOFARMACIA20092010-116
100Facultad de QuímicaLicenciaturaBIOFARMACIA20092009-241
101Facultad de QuímicaLicenciaturaBIOFARMACIA20092009-220
102Facultad de QuímicaLicenciaturaFARMACOGNOSIA20092009-21
103Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20092009-264
104Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20082009-168
105Facultad de QuímicaLicenciaturaBIOFARMACIA20082009-121
106Facultad de QuímicaLicenciaturaBIOFARMACIA20082009-139
107Facultad de QuímicaMaestríaTEMAS SELECTOS20082009-13
108Facultad de QuímicaMaestríaTEMAS SELECTOS20082008-23
109Facultad de QuímicaLicenciaturaBIOFARMACIA20082008-240
110Facultad de QuímicaLicenciaturaATENCION FARMACEUTICA20082008-271
111Facultad de QuímicaLicenciaturaBIOFARMACIA20072008-139
112Facultad de QuímicaMaestríaTEMAS SELECTOS20072008-15
Descargar PDF

Patentes Otorgadas

# Título Inventores Año Sección
1PROCESO PARA LA OBTENCION DE LOS ENANTIOMEROS DEL PRAZIQUANTEL Y SUS DERIVADOS 4´-HIDROXILADOS.MARIA ISABEL AGUILAR LAURENTS, HELGI HELENE GISELA FRANZISKA JUNG COOK, ALBERTO CEDILLO CRUZ, 2019CHEMISTRY; METALLURGYHUMAN NECESSITIES
2PROCESO PARA LA OBTENCION DE LOS ENANTIOMEROS DEL PRAZIQUANTEL Y SUS DERIVADOS 4'-HIDROXILADOS.ALBERTO CEDILLO CRUZ, HELGI HELENE GISELA FRANZISKA JUNG COOK, MARIA ISABEL AGUILAR LAURENTS, 2021CHEMISTRY; METALLURGYHUMAN NECESSITIES
Descargar PDF

No se encuentran registros en la base de datos de libros completos (Humanindex).

Descargar PDF

Capítulos de libros (Humanindex)

# Título del libro Título del capítulo ISBN Editorial Año Fuente